Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy.

Erik HeegJ X HarmelingB E BechererP J Marang-van de MheenM T F D Vrancken PeetersM A M Mureau

Published in: The British journal of surgery (2019)

Postmastectomy IBR marginally reduced the likelihood of receiving adjuvant chemotherapy within 6 weeks, but not within 9 or 12 weeks. Thus, IBR is not contraindicated in patients who need adjuvant chemotherapy after mastectomy.

Keyphrases

breast reconstruction
gestational age
cross sectional